Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2006 Oct 25;44(12):4587–4588. doi: 10.1128/JCM.01458-06

Detection of Giardia lamblia Antigens in Human Fecal Specimens by a Solid-Phase Qualitative Immunochromatographic Assay

Lynne S Garcia 1,*, John Paul Garcia 2
PMCID: PMC1698425  PMID: 17065273

Abstract

The SIMPLE-READ Giardia rapid assay (Medical Chemical Corporation) is a solid-phase qualitative immunochromatographic assay that detects Giardia lamblia in aqueous extracts of human fecal specimens. Testing 106 Giardia-positive and 104 Giardia-negative stool specimens yielded a sensitivity of 97.2% and a specificity of 100% for the SIMPLE-READ Giardia rapid assay.


Revised ordering options related to diagnostic parasitology testing include ova and parasite (O&P) examinations, the newer fecal immunoassays, and special stains for the coccidia and microsporidia. Laboratories are incorporating these procedures into their test menus, and each of the three test options has very specific benefits in terms of clinically relevant testing. While the use of routine diagnostic methods such as fecal concentration, permanent stained smears, and modified acid-fast staining may be insufficient to demonstrate the presence of intestinal parasites, antigen detection assays for Cryptosporidium spp. and Giardia lamblia have proven to be very useful (1-9, 12-15).

As acute infections with G. lamblia resolve, the number of organisms shed in the stool varies dramatically and the number of cysts passed by patients, including those who may be compromised, varies from day to day and week to week, particularly if they do not have diarrhea (10).

The nonenzymatic rapid immunoassay for Giardia antigens (SIMPLE-READ Giardia rapid assay; Medical Chemical Corp.) was performed in approximately 10 min on formalin-fixed (5 or 10% formalin or sodium acetate-acetic acid-formalin) stool specimens. Sample treatment buffer (4 to 6 drops) was added to a tube, followed by 1 drop of the uncentrifuged stool specimen. After the sample was mixed, it was immediately poured into the membrane flow test device. Using specific antibodies, Giardia antigens are isolated and immobilized on the substrate. Since the specimens were submitted in fixative, no mixing of the fecal sample was required prior to sampling; fluid above the stool was used, since the antigen was in solution. The assay results were read visually after 10 min. Positive results were seen as pink lines (regardless of intensity) on the membrane in the results window. A control was included in the device and visually appeared as a strong pink line.

In this study, the cartridge was tested against unconcentrated known positive and negative 10% formalin- or sodium acetate-acetic acid-formalin-preserved fecal specimens. The known positive and negative results were based on the reference methods, which were the O&P examination (concentration and permanent stained smear), the Meridian Bioscience, Inc., Giardia/Cryptosporidium Merifluor FA reagent, and the Medical-Chemical Corp. Para-Tect Giardia/Cryptosporidium FA reagent. For discrepant results obtained using the cartridge, if the specimen was positive by any two reference methods, the specimen was considered a true positive. Three specimens that tested negative using the cartridge were confirmed as true positives with very low parasite numbers by both of the more sensitive FA reference methods. Four specimens determined to be positive using the cartridge were originally considered negative based on the O&P examination; however, when retested, the four specimens were confirmed as true positives using the two FA reference methods.

Of the 210 specimens examined, 106 were positive for Giardia based on the results of the reference methods. Different parasites (10 protozoa, including trophozoites, cysts, and oocysts; seven helminths, including eggs and larvae; and four specimens containing human cells [polymorphonuclear leukocytes and macrophages]) were included in the negative specimens (n = 104). Both positive and negative specimens were tested by the two sites, 158 at LSG & Associates and 52 at the VA Greater Los Angeles facility. The known positive and negative specimens were randomly assigned to the two testing sites. All specimens were patient specimens, not seeded specimens, and some contained multiple organisms. Specific organisms included Blastocystis hominis (n = 16), Cryptosporidium spp. (n = 34), Cyclospora cayetanensis (n = 1), Chilomastix mesnili (n = 1), Dientamoeba fragilis (n = 6), Endolimax nana (n = 23), Entamoeba coli (n = 12), Entamoeba hartmanni (n = 1), Entamoeba histolytica/Entamoeba dispar (n = 7), Iodamoeba bütschlii (n = 3), Ascaris lumbricoides (n = 7), Diphyllobothrium latum (n = 1), Enterobius vermicularis (n = 5), Hymenolepis nana (n = 8), Strongyloides stercoralis (n = 4), Taenia spp. (n = 3), and Trichuris trichiura (n = 3). Although the results of the reference methods were known, the specimens were coded and tested blind when the SIMPLE-READ cartridge was used.

After resolution, the total number of positive specimens was 106, the sensitivity was 97.2%, the specificity was 100%, the positive predictive value (predictive value of a positive test result) was 100%, and the negative predictive value (predictive value of a negative test result) was 97.2% (Table 1). False-negative G. lamblia results were obtained from three specimens with low parasite numbers (one or two cysts/well using immunofluorescence). No cross-reactions were seen with other parasites.

TABLE 1.

Comparison of results with the reference methods and the SIMPLE-READ cartridgea

SIMPLE-READ cartridge result No. of specimens with reference method result ofb:
Positive Negative Total
Positive 103 0 103
Negative 3c 104 107
Total 106 104 210
a

The sensitivity was 97.2%, the specificity was 100%, the positive predictive value (predictive value of a positive test result) was 100%, and the negative predictive value (predictive value of a negative test result) was 97.2%.

b

Reference methods: O&P examination, Giardia/Cryptosporidium Merifluor FA reagent (Meridian Bioscience, Inc.), and Para-Tect Giardia/Cryptosporidium FA reagent (Medical-Chemical Corp.).

c

False-negative G. lamblia results were obtained from three specimens with very low parasite numbers. Both FA reference methods confirmed these specimens as true positives.

In patients with giardiasis, the use of routine diagnostic methods such as concentration and permanent stain may be insufficient to demonstrate the presence of these organisms (5, 15). Although the fecal immunoassays are more sensitive than the routine O&P method, false-negative results may still occur with very light infections. It has been recommended that a second specimen be tested if the first fecal immunoassay for suspected giardiasis is negative (11).

Although the reagent costs may be more than those for the routine O&P methods, the labor costs will be considerably less when using the rapid cartridge format. When comparing diagnostic test costs, it is important to consider all aspects of testing including, but not limited to, reagents, labor, repeat tests, quality control, reagent storage, number of tests requested, staff expertise in microscopy, and training requirements.

The ability to detect Giardia antigens in formalin-fixed or unfixed fecal specimens with a 10-min nonenzymatic immunoassay provides the user with another useful diagnostic kit, the SIMPLE-READ Giardia rapid assay (Medical Chemical Corp.), which can also be used at the point of service like other rapid immunoassays currently available. The rapid immunoassays do not take the place of routine O&P examinations, but they are more sensitive and clinically relevant when trying to diagnose specific infections such as giardiasis (5).

Acknowledgments

We thank Medical Chemical Corporation for providing the SIMPLE-READ diagnostic kits and the confirmative diagnostic kits.

We thank Medical Chemical Corporation for financial support.

Footnotes

Published ahead of print on 25 October 2006.

REFERENCES

  • 1.Aldeen, W. E., K. Carroll, A. Robison, M. Morrison, and D. Hale. 1998. Comparison of nine commercially available enzyme-linked immunosorbent assays for detection of Giardia lamblia in fecal specimens. J. Clin. Microbiol. 36:1338-1340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Boone, J. H., T. D. Wilkins, T. E. Nash, J. E. Brandon, E. A. Macias, R. C. Jerris, and D. M. Lyerly. 1999. TechLab and Alexon Giardia enzyme-linked immunosorbent assay kits detect cyst wall protein 1. J. Clin. Microbiol. 37:611-614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chan, R., J. Chen, M. K. York, N. Setijono, R. L. Kaplan, F. Graham, and H. B. Tanowitz. 2000. Evaluation of a combination rapid immunoassay for detection of Giardia and Cryptosporidium antigens. J. Clin. Microbiol. 38:393-394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Garcia, L. S. 2007. Diagnostic medical parasitology, 5th ed. ASM Press, Washington, D.C.
  • 5.Garcia, L. S., and R. Y. Shimizu. 1997. Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for the detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens. J. Clin. Microbiol. 35:1526-1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Garcia, L. S., and R. Y. Shimizu. 2000. Detection of Giardia lamblia and Cryptosporidium parvum antigens in human fecal specimens using the ColorPAC combination rapid solid-phase qualitative immunochromatographic assay. J. Clin. Microbiol. 38:1267-1268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Garcia, L. S., R. Y. Shimizu, and C. N. Bernard. 2000. Detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum antigens in human fecal specimens using the Triage Parasite Panel enzyme immunoassay. J. Clin. Microbiol. 38:3337-3340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Garcia, L. S., R. Y. Shimizu, S. Novak, M. Carroll, and F. Chan. 2003. Commercial assay for detection of Giardia lamblia and Cryptosporidium parvum antigens in human fecal specimens by rapid solid-phase qualitative immunochromatography. J. Clin. Microbiol. 41:209-212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Garcia, L. S., A. C. Shum, and D. A. Bruckner. 1992. Evaluation of a new monoclonal antibody combination reagent for direct fluorescent detection of Giardia cysts and Cryptosporidium oocysts in human fecal specimens. J. Clin. Microbiol. 30:3255-3257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Handoussa, A. E., M. M. Helmy, E. M. Hussein, and H. I. El-Nimr. 2005. Degree of symptoms versus copro-antigen levels in Giardia lamblia infection. J. Egypt. Soc. Parasitol. 35:69-81. [PubMed] [Google Scholar]
  • 11.Hanson, K. L., and C. P. Cartwright. 2001. Use of an enzyme immunoassay does not eliminate the need to analyze multiple stool specimens for sensitive detection of Giardia lamblia. J. Clin. Microbiol. 39:474-477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Katanik, M. T., S. K. Schneider, J. E. Rosenblatt, G. S. Hall, and G. W. Procop. 2001. Evaluation of ColorPAC Giardia/Cryptosporidium rapid assay and ProSpecT Giardia/Cryptosporidium microplate assay for detection of Giardia and Cryptosporidium in fecal specimens. J. Clin. Microbiol. 39:4523-4525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Rosenblatt, J. E., L. M. Sloan, and S. K. Schneider. 1993. Evaluation of an enzyme-linked immunosorbent assay for the detection of Giardia lamblia in stool specimens. Diagn. Microbiol. Infect. Dis. 16:337-341. [DOI] [PubMed] [Google Scholar]
  • 14.Rosoff, J. D., C. A. Sanders, S. S. Sonnad, P. R. De Lay, W. K. Hadley, F. F. Vincenzi, D. M. Yajko, and P. D. O'Hanley. 1989. Stool diagnosis of giardiasis using a commercially available enzyme immunoassay to detect Giardia-specific antigen 65 (GSA 65). J. Clin. Microbiol. 27:1997-2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zimmerman, S. K., and C. A. Needham. 1995. Comparison of conventional stool concentration and preserved-smear methods with Merifluor Cryptosporidium/Giardia direct immunofluorescence assay and ProSpecT Giardia EZ microplate assay for detection of Giardia lamblia. J. Clin. Microbiol. 33:1942-1943. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES